Health Warning for Funds
The contents of this document and related product/offering documents or information provided by the issuer have not been reviewed by the Hong Kong Securities & Futures Commission (“SFC”), the Monetary Authority of Singapore (“MAS”) or any regulatory authority in Hong Kong or Singapore, and you are advised to exercise caution in relation to this document and related product/offering documents or information. If you are in doubt about any of the contents of this document and related product/offering documents or information, you should obtain independent professional advice.
This document may involve complex funds, which may involve derivatives and/or loss absorption features, etc. In particular, please take note that funds that mainly invest in, or whose returns are closely linked to the performance of, bonds with loss absorption features (i.e. underlyings) are high risk and complex products, as the circumstances in which these underlyings may be required to bear losses are difficult to predict and ex ante assessments of the quantum of loss will also be highly uncertain. Investors should exercise caution in relation to the products. Such products are generally not suitable for retail investors. Do not invest in it unless you fully understand and are willing to assume the risks associated with it. Prior to entering into a transaction or investing in any product, investors should fully understand the terms, conditions and features of such product as well as the risks and merits of entering into the transaction/investing in such product, and consult their own legal, regulatory, tax, financial and account advisors before making the investment. Where past performance information is provided, such past performance is not indicative of future performance. Various fees (including standard trading costs, brokerage fee and other charges) and market conditions will impact net returns. If you are in any doubt about the risks involved in the product, you should seek appropriate professional advice.
Where any products described herein may be authorized by the SFC, such authorization does not imply official recommendation or that SFC authorization is not a recommendation or endorsement of any product nor does it guarantee the commercial merits of any product or its performance. Notwithstanding other provisions in this document, products described herein may not be authorized by the SFC and may be offered in Hong Kong only to "professional investors" within the meaning of the Securities and Futures Ordinance (Cap. 571 of the Laws of Hong Kong) and any rules made thereunder. Products described herein may not be authorized by the MAS and may be offered in Singapore only to "accredited investors" within the meaning of the Securities and Futures Act 2001.
Each product described herein is not equivalent and should not be treated as a substitute for a term deposit. It is not a protected deposit and is not protected or insured under the Deposit Protection Scheme in Hong Kong and the Deposit Insurance Scheme in Singapore.
PRODUCT/OFFERING DOCUMENTS and/or INFORMATION PROVIDED BY THE ISSUER cannot disclose all possible risks of the products.
Terms may be defined differently under specific issues. Investors should read and understand the relevant brochures, as well as the termsheet, prospectus and all other offering documents (together, the "Documents"), in particular the risk factors, for further details.
Health Warning for Bonds
The contents of this document and related product/offering documents or information provided by the issuer(s) have not been reviewed by the Hong Kong Securities & Futures Commission (“SFC”), the Monetary Authority of Singapore (“MAS”) or any regulatory authority in Hong Kong or Singapore, and you are advised to exercise caution in relation to this document and related product/offering documents or information. If you are in doubt about any of the contents of this document and related product/offering documents or information, you should obtain independent professional advice.
This document may involve complex bonds, which may involve derivatives and/or special features (such as loss absorption, perpetual, subordinated, discretionary coupons, exchangeable, contingent write-down, convertible, extendable maturity dates, with multiple credit support providers, etc.), and/or have generally subordinated status, and investors should exercise caution in relation to such products. In particular, please take note that bonds with loss absorption features are high risk and complex products, as the circumstances in which each such product may be required to bear losses are difficult to predict and ex ante assessments of the quantum of loss will also be highly uncertain. Such products are generally not suitable for retail investors. Do not invest in them unless you fully understand and are willing to assume the risks associated with them. Prior to entering into a transaction or investing in any product, investors should fully understand the terms, conditions and features of such product as well as the risks and merits of investing in such product, and consult their own legal, regulatory, tax, financial and account advisors before making the investment. Where past performance information is provided, such past performance is not indicative of future performance. Various fees (including standard trading costs, brokerage fee and other charges) and market conditions will impact net returns. If you are in any doubt about the risks involved in any product, you should seek appropriate professional advice.
Where any products described herein may be authorized by the SFC, such authorization does not imply official recommendation and is not a recommendation or endorsement of any product nor does it guarantee the commercial merits of any product or its performance. Notwithstanding other provisions in this document, products described herein may not be authorized by the SFC and may be offered in Hong Kong only to "professional investors" within the meaning of the Securities and Futures Ordinance (Cap. 571 of the Laws of Hong Kong) and any rules made thereunder. Products described herein may not be authorized by the MAS and may be offered in Singapore only to "accredited investors" within the meaning of the Securities and Futures Act 2001.
Each product described herein is not equivalent and should not be treated as a substitute for a term deposit. It is not a protected deposit and is not protected or insured under the Deposit Protection Scheme in Hong Kong and the Deposit Insurance Scheme in Singapore.
PRODUCT/OFFERING DOCUMENTS and/or INFORMATION PROVIDED BY THE ISSUER cannot disclose all possible risks of the products.
Terms may be defined differently under specific issues. Investors should read and understand the relevant brochures, as well as the termsheet, prospectus/issuance programme and all other offering documents (together, the "Documents"), in particular the risk factors, for further details.
Health Warning for Structured Products/Derivatives
The contents of this document and related product/offering documents or information provided by the issuer have not been reviewed by the Hong Kong Securities & Futures Commission (“SFC”), the Monetary Authority of Singapore (“MAS”) or any regulatory authority in Hong Kong or Singapore, and you are advised to exercise caution in relation to this document and related product/offering documents or information. If you are in doubt about any of the contents of this document and related product/offering documents or information, you should obtain independent professional advice.
This is a complex structured product, which involves derivatives. In particular, please take note that structured products that invest mainly in, or whose returns are closely linked to the performance of, bonds with loss absorption features (i.e. underlyings) are high risk and complex products, as the circumstances in which these underlyings may be required to bear losses are difficult to predict and ex ante assessments of the quantum of loss will also be highly uncertain. Investors should exercise caution in relation to the product. Such products are generally not suitable for retail investors. Do not invest in it unless you fully understand and are willing to assume the risks associated with it. Prior to entering into a transaction or investing in any product, investors should fully understand the terms, conditions and features of such product as well as the risks and merits of entering into the transaction/investing in such product, and consult their own legal, regulatory, tax, financial and account advisors before making the investment. Where past performance information is provided, such past performance is not indicative of future performance. Various fees (including standard trading costs, brokerage fee and other charges) and market conditions will impact net returns. If you are in any doubt about the risks involved in the product, you should seek appropriate professional advice.
Notwithstanding other provisions in this document, products described herein are not authorized by the SFC and may be offered in Hong Kong only to "professional investors" within the meaning of the Securities and Futures Ordinance (Cap. 571 of the Laws of Hong Kong) and any rules made thereunder. Products described herein are not authorized by the MAS and may be offered in Singapore only to "accredited investors" within the meaning of the Securities and Futures Act 2001.
Each product is not equivalent and should not be treated as a substitute for a term deposit. It is not a protected deposit and is not protected or insured under the Deposit Protection Scheme in Hong Kong and the Deposit Insurance Scheme in Singapore.
PRODUCT/OFFERING DOCUMENTS and/or INFORMATION PROVIDED BY THE ISSUER cannot disclose all possible risks of the products.
Terms may be defined differently under specific issues. Investors should read and understand the relevant brochures, as well as the termsheet, prospectus and other offering documents (together, the "Documents"), in particular the risk factors, for further details.
風險警告
本文件及發行人提供之相關產品/發售文件或資料的內容並未經香港證券及期貨事務監察委員會（「香港證監會」）、新加坡金融管理局（「新加坡金管局」）或香港或新加坡的任何監管機構審閱，務請閣下就本文件及相關產品/發售文件或資料謹慎行事。如閣下對本文件及相關產品/發售文件或資料的任何內容有任何疑問，應尋求獨立的專業意見。
本文件可能涉及複雜基金，該等基金可能涉及衍生工具和/或吸收虧損特徵等。請注意，此等主要投資於或其收益與具有吸收虧損特徵的債券表現密切掛鉤的基金（即標的）屬於高風險的複雜產品，因為此等標的承擔損失的情況難以預測，而且事前對損失量的評估也非常不確定。此等產品通常不適合散戶投資者。除非閣下已完全瞭解並同意接受所有風險，否則閣下不應對這些産品進行投資。投資者在訂立任何一項交易或對任何產品作出投資前，應充份了解産品/投資的條款、細則及特徵，以及投資該產品的風險和優點，並在作出投資前諮詢其法律、監管、稅務、財務及會計顧問。如本文件及相關產品/要約文件有提供過往表現資料，則此類過往表現並非未來業績指標。各種費用(包括標準交易成本、經紀費用及其他收費)及市況將影響淨回報。若閣下對産品風險有任何疑問，應尋求獨立專業意見。
若任何本文件所述產品已獲香港證監會認可，該認可並不表示獲得官方推介且並非對任何產品所作之推介或認許，亦不是對任何產品的商業利弊或表現作出保證。儘管本文件可能另有規定，本文件所述産品並未獲得香港證監會的認可且僅可在香港發售予「專業投資者」（定義見《證券及期貨條例》（香港法例第571章）及據此制定的任何規則）。本文件所述産品並未獲得新加坡金融管理局監管的認可且僅可在新加坡發售予「認可投資者」(accredited investors)（定義見新加坡法例《證券及期貨法》(Securities and Futures Act 2001)）。
本文件所述每個産品並不等同於定期存款，亦不應被視爲定期存款之替代産品。本産品並不屬受保障存款、及不受香港《存款保障計劃》及新加坡Deposit Insurance Scheme保障或保險。
產品/發售文件及/或發行人提供之相關資料未能披露產品的所有可能風險。
個別發行中，條款可有不同定義。投資者應閱讀並理解相關産品手册及條款清單、發行章程以及所有其他發售文件（統稱「產品文件」），尤其是風險因素，以知詳情。
風險警告
本文件及發行人提供之相關產品/發售文件或資料的內容並未經香港證券及期貨事務監察委員會（「香港證監會」）、新加坡金融管理局（「新加坡金管局」）或香港或新加坡的任何監管機構審閱，務請閣下就本文件及相關產品/發售文件或資料謹慎行事。如閣下對本文件及相關產品/發售文件或資料的任何內容有任何疑問，應尋求獨立的專業意見。
本文件可能涉及複雜債券，該等債券可能涉及衍生工具和/或特定特徵（例如吸收虧損、永續、次級、酌情支付票息、可交換、應急減記、股權轉換、可展期、擁有多個信貸支持提供商等）和/或普遍爲次級債券，投資者應就此等產品謹慎行事。請注意，此等有吸收虧損特徵的債券屬於高風險的複雜產品，因為此類產品承擔損失的情況難以預測，而且事前對損失量的評估也非常不確定。此等產品通常不適合散戶投資者。除非閣下已完全瞭解並同意接受所有風險，否則閣下不應對這些産品進行投資。投資者在訂立任何一項交易或對任何產品作出投資前，應充份了解産品/投資的條款、細則及特徵，以及投資該產品的風險和優點，並在作出投資前諮詢其法律、監管、稅務、財務及會計顧問。如本文件及相關產品/要約文件有提供過往表現資料，則此類過往表現並非未來業績指標。各種費用(包括標準交易成本、經紀費用及其他收費)及市況將影響淨回報。若閣下對産品風險有任何疑問，應尋求獨立專業意見。
若任何本文件所述產品已獲香港證監會認可，該認可並不表示獲得官方推介且並非對任何產品所作之推介或認許，亦不是對任何產品的商業利弊或表現作出保證。儘管本文件可能另有規定，本文件所述産品並未獲得香港證監會的認可且僅可在香港發售予「專業投資者」（定義見《證券及期貨條例》（香港法例第571章）及據此制定的任何規則）。本文件所述産品並未獲得新加坡金融管理局監管的認可且僅可在新加坡發售予「認可投資者」 (accredited investors)（定義見新加坡法例《證券及期貨法》(Securities and Futures Act 2001)）。本文件所述每個産品並不等同於定期存款，亦不應被視爲定期存款之替代産品。本産品並不屬受保障存款、及不受香港《存款保障計劃》及新加坡Deposit Insurance Scheme保障或保險。
產品/發售文件及/或發行人提供之相關資料未能披露產品的所有可能風險。
個別發行中，條款可有不同定義。投資者應閱讀並理解相關産品手册及條款清單、發行章程/發行計劃以及所有其他發售文件（統稱「產品文件」），尤其是風險因素，以知詳情。
風險警告
本文件及發行人提供之相關產品/發售文件或資料的內容並未經香港證券及期貨事務監察委員會（「香港證監會」）、新加坡金融管理局（「新加坡金管局」）或香港或新加坡的任何監管機構審閱，務請閣下就本文件及相關產品/發售文件或資料謹慎行事。如閣下對本文件及相關產品/發售文件或資料的任何內容有任何疑問，應尋求獨立的專業意見。
這是涉及衍生工具的複雜結構性產品。請注意，此等主要投資於或其收益與具有吸收虧損特徵的債券表現密切掛鉤的結構性產品（即標的）屬於高風險的複雜產品，因為此等標的承擔損失的情況難以預測，而且事前對損失量的評估也非常不確定。此等產品通常不適合散戶投資者。除非閣下已完全瞭解並同意接受所有風險，否則閣下不應對這些産品進行投資。投資者在訂立任何一項交易或對任何產品作出投資前，應充份了解産品/投資的條款、細則及特徵，以及投資該產品的風險和優點，並在作出投資前諮詢其法律、監管、稅務、財務及會計顧問。如本文件及相關產品/要約文件有提供過往表現資料，則此類過往表現並非未來業績指標。各種費用(包括標準交易成本、經紀費用及其他收費)及市況將影響淨回報。若閣下對産品風險有任何疑問，應尋求獨立專業意見。
儘管本文件可能另有規定，本文件所述産品並未獲得香港證監會的認可且僅可在香港發售予「專業投資者」（定義見《證券及期貨條例》（香港法例第571章）及據此制定的任何規則）。本文件所述産品並未獲得新加坡金融管理局監管的認可且僅可在新加坡發售予「認可投資者」(accredited investors)（定義見新加坡法例《證券及期貨法》(Securities and Futures Act 2001)）。本文件所述每個産品並不等同於定期存款，亦不應被視爲定期存款之替代産品。本産品並不屬受保障存款、及不受香港《存款保障計劃》及新加坡Deposit Insurance Scheme保障或保險。
產品/發售文件及/或發行人提供之相關資料未能披露產品的所有可能風險。
個別發行中，條款可有不同定義。投資者應閱讀並理解相關産品手册及條款清單、發行章程以及所有其他發售文件（統稱「產品文件」），尤其是風險因素，以知詳情。
风险警告
本文件及发行人提供之相关产品/发售文件或资料的内容并未经香港证券及期货事务监察委员会（“香港证监会”）、新加坡金融管理局（“新加坡金管局”）或香港或新加坡的任何监管机构审阅，务请阁下就本文件及相关产品/发售文件或资料谨慎行事。如阁下对本文件及相关产品/发售文件或资料的任何内容有任何疑问，应寻求独立的专业意见。
本文件可能涉及复杂基金，该等基金可能涉及衍生工具和/或吸收亏损特征等。请注意，此等主要投资于或其收益与具有吸收亏损特征的债券表现密切挂钩的基金（即标的）属于高风险的复杂产品，因为此等标的承担损失的情况难以预测，而且事前对损失量的评估也非常不确定。此等产品通常不适合散户投资者。除非阁下已完全了解并同意接受所有风险，否则阁下不应对这些产品进行投资。投资者在订立任何一项交易或对任何产品作出投资前，应充分了解产品/投资的条款、细则及特征，以及投资该产品的风险和优点，并在作出投资前咨询其法律、监管、税务、财务及会计顾问。如本文件及相关产品/要约文件有提供过往表现资料，则此类过往表现并非未来业绩指标。各种费用(包括标准交易成本、经纪费用及其他收费)及市况将影响净回报。若阁下对产品风险有任何疑问，应寻求独立专业意见。
若任何本文件所述产品已获香港证监会认可，该认可并不表示获得官方推介且并非对任何产品所作之推介或认许，亦不是对任何产品的商业利弊或表现作出保证。尽管本文件可能另有规定，本文件所述产品并未获得香港证监会的认可且仅可在香港发售予“专业投资者”（定义见《证券及期货条例》（香港法例第571章）及据此制定的任何规则）。本文件所述产品并未获得新加坡金融管理局监管的认可且仅可在新加坡发售予“认可投资者” (accredited investors)（定义见新加坡法例《证券及期货法》(Securities and Futures Act 2001)）。
本文件所述每个产品并不等同于定期存款，亦不应被视为定期存款之替代产品。本产品并不属受保障存款、及不受香港《存款保障计划》及新加坡Deposit Insurance Scheme保障或保险。
产品/发售文件及/或发行人提供之相关资料未能披露产品的所有可能风险。
个别发行中，条款可有不同定义。投资者应阅读并理解相关产品手册及条款清单、发行章程以及所有其他发售文件（统称“产品文件”），尤其是风险因素，以知详情。
风险警告
本文件及发行人提供之相关产品/发售文件或资料的内容并未经香港证券及期货事务监察委员会（“香港证监会”）、新加坡金融管理局（“新加坡金管局”）或香港或新加坡的任何监管机构审阅，务请阁下就本文件及相关产品/发售文件或资料谨慎行事。如阁下对本文件及相关产品/发售文件或资料的任何内容有任何疑问，应寻求独立的专业意见。
本文件可能涉及复杂债券，该等债券可能涉及衍生工具和/或特定特征（例如吸收亏损、永续、次级、酌情支付票息、可交换、应急减记、股权转换、可展期、拥有多个信贷支持提供商等）和/或普遍为次级债券，投资者应就此等产品谨慎行事。请注意，此等有吸收亏损特征的债券属于高风险的复杂产品，因为此类产品承担损失的情况难以预测，而且事前对损失量的评估也非常不确定。此等产品通常不适合散户投资者。除非阁下已完全了解并同意接受所有风险，否则阁下不应对这些产品进行投资。投资者在订立任何一项交易或对任何产品作出投资前，应充分了解产品/投资的条款、细则及特征，以及投资该产品的风险和优点，并在作出投资前咨询其法律、监管、税务、财务及会计顾问。如本文件及相关产品/要约文件有提供过往表现资料，则此类过往表现并非未来业绩指标。各种费用(包括标准交易成本、经纪费用及其他收费)及市况将影响净回报。若阁下对产品风险有任何疑问，应寻求独立专业意见。
若任何本文件所述产品已获香港证监会认可，该认可并不表示获得官方推介且并非对任何产品所作之推介或认许，亦不是对任何产品的商业利弊或表现作出保证。尽管本文件可能另有规定，本文件所述产品并未获得香港证监会的认可且仅可在香港发售予“专业投资者”（定义见《证券及期货条例》（香港法例第571章）及据此制定的任何规则）。本文件所述产品并未获得新加坡金融管理局监管的认可且仅可在新加坡发售予“认可投资者” (accredited investors)（定义见新加坡法例《证券及期货法》(Securities and Futures Act 2001)）。本文件所述每个产品并不等同于定期存款，亦不应被视为定期存款之替代产品。本产品并不属受保障存款、及不受香港《存款保障计划》及新加坡Deposit Insurance Scheme保障或保险。
产品/发售文件及/或发行人提供之相关资料未能披露产品的所有可能风险。
个别发行中，条款可有不同定义。投资者应阅读并理解相关产品手册及条款清单、发行章程/发行计划以及所有其他发售文件（统称“产品文件”），尤其是风险因素，以知详情。
风险警告
本文件及发行人提供之相关产品/发售文件或资料的内容并未经香港证券及期货事务监察委员会（“香港证监会”）、新加坡金融管理局（“新加坡金管局”）或香港或新加坡的任何监管机构审阅，务请阁下就本文件及相关产品/发售文件或资料谨慎行事。如阁下对本文件及相关产品/发售文件或资料的任何内容有任何疑问，应寻求独立的专业意见。
这是涉及衍生工具的复杂结构性产品。请注意，此等主要投资于或其收益与具有吸收亏损特征的债券表现密切挂钩的结构性产品（即标的）属于高风险的复杂产品，因为此等标的承担损失的情况难以预测，而且事前对损失量的评估也非常不确定。此等产品通常不适合散户投资者。除非阁下已完全了解并同意接受所有风险，否则阁下不应对这些产品进行投资。投资者在订立任何一项交易或对任何产品作出投资前，应充分了解产品/投资的条款、细则及特征，以及投资该产品的风险和优点，并在作出投资前咨询其法律、监管、税务、财务及会计顾问。如本文件及相关产品/要约文件有提供过往表现资料，则此类过往表现并非未来业绩指标。各种费用(包括标准交易成本、经纪费用及其他收费)及市况将影响净回报。若阁下对产品风险有任何疑问，应寻求独立专业意见。
尽管本文件可能另有规定，本文件所述产品并未获得香港证监会的认可且仅可在香港发售予“专业投资者”（定义见《证券及期货条例》（香港法例第571章）及据此制定的任何规则）。本文件所述产品并未获得新加坡金融管理局监管的认可且仅可在新加坡发售予“认可投资者” (accredited investors)（定义见新加坡法例《证券及期货法》(Securities and Futures Act 2001)）。本文件所述每个产品并不等同于定期存款，亦不应被视为定期存款之替代产品。本产品并不属受保障存款、及不受香港《存款保障计划》及新加坡Deposit Insurance Scheme保障或保险。
产品/发售文件及/或发行人提供之相关资料未能披露产品的所有可能风险。
个别发行中，条款可有不同定义。投资者应阅读并理解相关产品手册及条款清单、发行章程以及所有其他发售文件（统称”产品文件”），尤其是风险因素，以知详情。